A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Conclusions: COPD is a progressive disease, and available treatment options provide ... 10 mL vs placebo -60 mL (p = 0.16) COPD = chronic obstructive pulmonary disease; FEV 1 = forced expiratory ...

Although the most effective dose of cilomilast is 15 mg twice daily, it was shown to cause more adverse events than lower treatment ... COPD = chronic obstructive pulmonary disease; FEV 1 ...

A statement from Gilead indicates that the deal is likely to lower its 2025 GAAP and non-GAAP earnings per share by $0.15 to ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

In their study, the researchers looked at the effects of cigarette smoke on Mucosal-Associated Invariant T (MAIT) cells, a ...

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...